Author

Gema Santamaría Núñez

PharmaMar (Spain)ORCID 0000-0002-5455-2754Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:chromatin & epigenetic regulation· 1 Research Focus:differential expression· 1 Approach:experimental assay· 1 Organism:human· 1

Frequent Co-Authors

Amélie ZachayusiD· 1 shared Carmen CuevasiD· 1 shared Clara Capelli· 1 shared Clara Marechal· 1 shared Clémence Elly· 1 shared Emmanuel CompeiD· 1 shared Frédéric CoiniD· 1 shared Guillaume DavidsoniD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Amélie ZachayusORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cancer BiologyNature CommunicationsPeer-reviewedJan 8, 2025

Novel synthetic ecteinascidins exhibit potent anti-melanoma activity by suppressing super-enhancer-driven oncogenic transcription

Max Cigrang, Julian Obid, Maguelone Nogaret…·Frédéric Coin

This study shows novel synthetic ecteinascidins effectively treat melanoma by inhibiting super-enhancer-driven oncogenic transcription, even in resistant models.

16 citations

humanbulk RNA-seq

𝕏 PostBluesky